Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 24 Mar 2026 – 20 Aug 2026, limited by TRUSTMF Mid Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | TRUSTMF Mid Cap Fund | Nifty Midcap 150 |
|---|---|---|
| 24 Mar 2026 | ₹100.00 | ₹100.00 |
| 05 Apr 2026 | ₹98.90 | ₹99.37 |
| 18 Apr 2026 | ₹106.90 | ₹110.60 |
| 30 Apr 2026 | ₹107.10 | ₹110.38 |
| 13 May 2026 | ₹108.40 | ₹110.86 |
| 25 May 2026 | ₹111.50 | ₹113.86 |
| 07 Jun 2026 | ₹111.10 | ₹111.64 |
| 19 Jun 2026 | ₹115.00 | ₹115.26 |
| 01 Jul 2026 | ₹116.90 | ₹114.51 |
| 14 Jul 2026 | ₹117.90 | ₹115.66 |
| 26 Jul 2026 | ₹116.40 | ₹113.82 |
| 08 Aug 2026 | ₹120.90 | ₹117.22 |
| 20 Aug 2026 | ₹124.00 | ₹117.35 |
| Metric | Trust · Regular NAV ₹12.40 Very High risk Unrated | Category median Mid Cap Fund · 34 funds |
|---|---|---|
| — | +8.71% | |
| — | +18.06% | |
| — | +16.16% | |
| — | +15.69% | |
| +24.00% | +16.93% | |
| +57.60% | — | |
| — | +19.07% | |
| — | +16.56% | |
| — | +16.43% | |
| Risk | ||
| 12.95% | 16.23% | |
| — | 0.74 | |
| — | 1.00 | |
| -3.06% | -37.39% | |
| Nifty Midcap 150 | — | |
| — | +0.94% | |
| — | 0.94 | |
| — | 96.2% | |
| — | 90.1% | |
| 3.76% | 2.04% | |
| ₹221.86Cr | ₹7,594Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹1.00K | — | |
| — | 41% | |
| Aakash Manghani · 0.5y | — | |
| 24 Mar 2026 | — | |
| 70 | — | |
| 25.8% | — | |
| 5.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.